Sydney Morning Herald: ‘It’s American driven’ – US holds the keys to Asian inflation

This article was written by Lucy Battersby and published in The Sydney Morning Herald on April 3, 2021.

The US government holds the keys to the lock keeping inflation under control across Asia and Australia, with the head of Antipodes Asia Fund saying it could all come down to how much stimulus the Biden administration can pump into the US economy.

Rising consumer prices were already a post-earnings season concern for equity investors amid an accelerating economic rebound and the arrival of the Biden Administration’s $US1.9 trillion COVID relief package last month.

A further $US2.25 trillion in infrastructure spending – revealed by Biden last week – is seen as another likely inflation accelerant, further stoking concerns that central banks will raise rates sooner than expected to keep prices in check.

Biden’s bill still has to run the gauntlet through the US Senate – where it is likely to face opposition from Republicans and moderate Democrats – but Sunny Bangia, fund manager of the Antipodes Asia Fund, said the package nonetheless had the potential to drive prices upwards in Australia and in neighbouring countries.

“If the Biden administration were to implement an infrastructure stimulus, that would just put more pressure on commodity prices and that would probably put a huge pressure on commodity prices in Asia,” he said.

“Its unprecedented. It’s very US-driven. You don’t see the same inflationary pulse across Asia or Europe.”

Inflation concerns have been a key influence on equity markets both home and abroad in the post-earnings season period.

Yields on 10-year US government bonds entered the Easter break at near pre-pandemic highs, while long-dated yields in Australia are near levels not seen since April 2019, a sign economies are accelerating, and firming the perception a central bank rate hike will be brought forward.

High-growth sectors such as technology are particularly susceptible to rising bond yields, with investors more likely to turn to cyclical names instead of companies whose valuations have run red-hot.

Mr Bangia pointed out that China’s experience with inflation and leverage ten years ago had the government very sensitive to anything that could potentially create instability.

This was why the Chinese government stepped in to stop Jack Ma’s fintech Ant Group from floating on the Hong Kong stock exchange in late 2020, in what was expected to be the world’s largest float valued at $US34.5 billion.

“With the (Chinese) government, you go through these periods of regulatory enforcement,” he said.

“Typically it is because they want to fix something they think is not right for the nation. And you just have to work through it. Jack Ma made a big song and dance, but the path that (Ant Group owner) Alibaba is taking is the right one. They are adapting and listening to the regulatory issues.”

Mr Bangia has been covering Asian equities for more than a decade, and recalls Chinese authorities working hard to get inflation down and de-leverage their economy after they released a 4 trillion RMB stimulus in 2008 (about $795 billion in today’s money).

He said while the US was now launching one of its biggest ever stimulus packages to help its own economy recovery from the COVID-19 pandemic, Asian stimulus this time around had been more private-sector driven and balanced.

“The greatest worry about inflation has been in the US. Less so in Asia and less so in Australia,” said Bangia.

“We haven’t seen this level of M2 (monetary supply) growth in the United States for a very long time. A lot of cash is hitting a lot of household balance sheets.”


Subscribe to receive the latest news and insights from the Antipodes team

Subscribe to updates


Feature Image: Sydney Morning Herald
This communication was prepared by Antipodes Partners Limited (ABN 29 602 042 035, AFSL 481 580) (Antipodes). Antipodes believes the information contained in this communication is based on reliable information, no warranty is given as to its accuracy and persons relying on this information do so at their own risk. This communication is for general information only and was prepared for multiple distribution and does not take account of the specific investment objectives of individual recipients and it may not be appropriate in all circumstances. Persons relying on this information should do so in light of their specific investment objectives and financial situations. Any person considering action on the basis of this communication must seek individual advice relevant to their particular circumstances and investment objectives. Subject to any liability which cannot be excluded under the relevant laws, Antipodes disclaim all liability to any person relying on the information contained on this website in respect of any loss or damage (including consequential loss or damage), however caused, which may be suffered or arise directly or indirectly in respect of such information.
Any opinions or forecasts reflect the judgment and assumptions of Antipodes on the basis of information at the date of publication and may later change without notice. Any projections are estimates only and may not be realised in the future. Information on this website is not intended as a securities recommendation or statement of opinion intended to influence a person or persons in making a decision in relation to investment. Unauthorised use, copying, distribution, replication, posting, transmitting, publication, display, or reproduction in whole or in part of the information contained on the website is prohibited without obtaining prior written permission from Antipodes.
Pinnacle Fund Services Limited ABN 29 082 494 362 AFSL 238371 is the product issuer of funds managed by Antipodes.  Any potential investor should consider the relevant Product Disclosure Statement available at www.antipodesonespartners.com when deciding whether to acquire, or continue to hold units in a fund. The issuer is not licensed to provide financial product advice.  Please consult your financial adviser before making a decision. Past performance is not a reliable indicator of future performance.
6 April 2021
Antipodes